April 1, 2016April 4, 2016

EMA Grants Orphan Medicinal Status to Eiger’s PAH Treatment Ubenimex

The European Medicines Agency (EMA) has granted Orphan Medicinal Product status to Eiger BioPharmaceuticals‘ Bestatin (ubenimex) for the treatment of pulmonary arterial hypertension (PAH). “We are very pleased with the EMA ... Read more

January 14, 2015January 14, 2015

Lung Therapeutics’ Empyema Drug Receives European Orphan Medicinal Product Status

News, Pneumonia

Pharmaceutical company Lung Therapeutics, Inc. has received the orphan medicinal product designation from the European Commission (EC) for its lead drug candidate LTI-01 for the treatment of empyema, a complication related to pneumonia. The status was ... Read more